-
Mashup Score: 9
Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences,
Source: www.businesswire.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Thrombosis Fellowship | Cleveland Clinic - 8 month(s) ago
Learn how Cleveland Clinic’s clinical thrombosis fellowship represents an advanced training opportunity for fellows with some exposure to hemostasis and thrombosis through prior medical training.
Source: my.clevelandclinic.orgCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 3Cleveland's Leading Local News: Weather, Traffic, Sports and more | Cleveland, Oh | wkyc.com - 8 month(s) ago
The latest news, sports, weather and traffic from WKYC 3 Studios for Cleveland and Northeast Ohio
Source: www.wkyc.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @2Scottish: VeloSano funds help power cancer research further down the road | https://t.co/5hFGtjNSZu. Excellent example of how @bikeV…
-
-
Mashup Score: 5Diffuse LAD and LV Thrombus as Possible Manifestation of Protein-S Deficiency in a Young Patient: - 8 month(s) ago
Abstract Patients with inherited hypercoagulopathies such as protein-S deficiency commonly present with venous thrombosis. However, there are rare cases of arterial thrombosis. We describe a rare c…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0
Background: Venous thromboembolism (VTE) is a known complication of coronavirus disease (COVID-19) in patients requiring hospitalization and intensive care. We …
Source: journals.sagepub.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Background: The natural history of patients with a pacemaker-related upper-extremity deep vein thrombosis (UEDVT) has not been consistently studied. Methods: We…
Source: journals.sagepub.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The ESC Textbook of Thrombosis - 8 month(s) ago
The ESC Textbook of Thrombosis is the third iteration of Therapeutic Advances in Thrombosis. Now a new addition to the European Society of Cardiology (ESC) publications portfolio, it is informed by the work of the ESC’s Working Group on Thrombosis. Written by internationally renowned experts in the field of thrombosis, the textbook presents an up-to-date and in-depth review of all aspects of thrombosis and antithrombotic therapies.
Source: global.oup.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
Learn more about lupus anticoagulants and the testing required for diagnosis from LaShanta Brice who is a scientific engagement and clinical educator at Stag…
Source: www.youtube.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6NBCA Journal Club - 8 month(s) ago
The NBCA Journal Club is a new series that highlights groundbreaking research in thrombosis and thrombophilia and features a manuscript author as part of the discussion.
Source: www.stoptheclot.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Calling all clinicians interested in #thrombosis and #thrombophilia research: Our new journal club meets 9/7 @ 3pm ET to discuss this paper with these distinguished experts. Join us! Register: https://t.co/Vgcp0XP9Q6 @elliotthaut @HopkinsMedicine @bryanacotton1 @Sunnybrook @UofT https://t.co/YyD6NqIIx7
-
-
Mashup Score: 13Diffuse LAD and LV Thrombus as Possible Manifestation of Protein-S Deficiency in a Young Patient: - 8 month(s) ago
Abstract Patients with inherited hypercoagulopathies such as protein-S deficiency commonly present with venous thrombosis. However, there are rare cases of arterial thrombosis. We describe a rare c…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
This is exciting news! Of course we would like to see the data but it certainly looks very promising to have an anticoagulant drug (FXI/XIa inhibitor) that is easy to use and even safer than current DOACs. #thrombosis #abelacimab #anticoagulant https://t.co/HhW5JK8G3d